Prostate Cancer Drug Zytiga May Extend Life
The newly approved prostate cancer pill Zytiga (abiraterone acetate) may extend life by up to four months among men with spreading cancer who have already been treated with chemotherapy, a study shows.
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.
The content has been reported and it will be reviewed by a moderator.
